PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsEstradiol valerate
Estradiol valerate
Activella, Amabelz, Angeliq, Bijuva, Climara, Combipatch, Delestrogen, Depo-testadiol, Ditate, Divigel, Elestrin, Estrace, Estradiol, Estrasorb, Estring, Estrogel, Etyqa, Evamist, Femring, Imvexxy, Ioa, Lunelle, Menostar, Minivelle, Myfembree, Natazia, Prefest, Ryeqo, Vagifem, Vivelle-dot, Zoely (estradiol valerate) is a small molecule pharmaceutical. Estradiol valerate was first approved as Estrace on 1982-01-01. It is used to treat breast neoplasms, hot flashes, hypogonadism, menorrhagia, and premature menopause amongst others in the USA. It has been approved in Europe to treat contraception and leiomyoma.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
signs and symptoms pathological conditionsD013568
therapeuticsD013812
reproductive and urinary physiological phenomenaD012101
Trade Name
FDA
EMA
Delestrogen (discontinued: Delestrogen)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Estradiol valerate
Tradename
Company
Number
Date
Products
DELESTROGENEndoN-009402 RX1982-01-01
2 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
aloraOTC monograph not final2019-09-18
bijuvaNew Drug Application2025-01-28
climaraNew Drug Application2023-12-06
climara proNew Drug Application2023-12-06
climarapro2009-01-20
delestrogenNew Drug Application2024-07-08
divigelNew Drug Application2023-11-21
elestrinNew Drug Application2024-02-27
estraceANDA2024-08-12
estradiol valerateANDA2025-11-10
Show 12 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
prostatic neoplasms—D011471C61
breast neoplasmsEFO_0003869D001943C50
menorrhagiaEFO_0003945D008595N92.0
primary ovarian insufficiencyEFO_0004266D016649E28.3
hot flashes—D019584—
hypogonadism—D007006E23.0
premature menopause—D008594E28.31
Agency Specific
FDA
EMA
Expiration
Code
ESTRADIOL / NORETHINDRONE ACETATE / RELUGOLIX, MYFEMBREE, MYOVANT SCIENCES
2026-01-27M-289
2025-12-18NCE
2025-08-05I-898
2024-05-26NP
ESTRADIOL, ESTRADIOL, CHEMO RESEARCH SL
2023-04-08CGT
Patent Expiration
Patent
Expires
Flag
FDA Information
Estradiol / Norethindrone Acetate / Relugolix, Myfembree, Myovant Sciences
117938122038-05-03U-2360
110335512037-09-29U-3129
117951782033-09-27DS, DP
93468222024-02-17U-3129
73009352024-01-28DP
80582802024-01-28DP
Estradiol, Imvexxy, Mayne Pharma
112666612034-02-02U-2316, U-2317
91800912033-12-20DPU-2316, U-2317
102586302033-12-20U-2316, U-2317
103987082033-12-20U-2317, U-2614
104710722033-06-18U-2316, U-2317
105688912033-06-18U-2316, U-2317
106680822033-06-18U-2316, U-2317
108885162033-06-18U-2316, U-2317
110651972033-06-18DP
111167172033-06-18DP
111232832033-06-18DP
92893822032-11-21DP
105375812032-11-21DPU-2316, U-2317
108066972032-11-21DP
108354872032-11-21U-2316, U-2317
112414452032-11-21U-2316, U-2317
112468752032-11-21U-2316, U-2317
113049592032-11-21DP
113511822032-11-21U-2316, U-2317
114977092032-11-21U-2316, U-2317
Estradiol / Progesterone, Bijuva, Mayne Pharma
86331782032-11-21DP
88466482032-11-21U-2439
88466492032-11-21DPU-2439
89330592032-11-21DPU-2439
89872372032-11-21DP
89935482032-11-21DP
89935492032-11-21DP
90062222032-11-21DPU-2439
91141452032-11-21U-2439
91141462032-11-21DPU-2439
93019202032-11-21DPU-2439
100523862032-11-21DP
102069322032-11-21U-2439
106393752032-11-21DP
106752882032-11-21U-2439
108067402032-11-21DPU-2439
110336262032-11-21DPU-2439
111035132032-11-21U-2439
111035162032-11-21DP
111100992032-11-21DP
111669632032-11-21DP
115293602032-11-21DP
117938192032-11-21U-2439
Drospirenone / Estradiol, Angeliq, Bayer Hlthcare
89068902031-10-22DP
Estradiol, Minivelle, Noven
82319062030-07-04DS, DP
97243102028-07-10DS, DP
97309002028-07-10U-2086
98334192028-07-10DP
Dienogest / Estradiol Valerate, Natazia, Bayer Hlthcare
81536162028-01-30U-1240
80715772026-05-13DPU-1
Estradiol Acetate, Femtrace, Apil
75727792025-10-02U-904
ATC Codes
No data
HCPCS
Code
Description
J1380
Injection, estradiol valerate, up to 10 mg
Clinical
Clinical Trials
1911 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50111240781138438
ContraceptionD003267——2418512027138
InfertilityD007246EFO_0000545—1112143368135
Healthy volunteers/patients———817755101
MenopauseD008593EFO_0003922N95191618272096
NeoplasmsD009369—C80482351567
Polycystic ovary syndromeD011085EFO_0000660E28.2738152658
PostmenopauseD017698——9121391150
AtrophyD001284——69225748
EndometriosisD004715EFO_0001065N802101791145
Show 165 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C61164410——62
Ovarian neoplasmsD010051EFO_0003893C5614121——22
Endometrial neoplasmsD016889EFO_0004230—7132—118
CarcinomaD002277—C80.0592—115
Non-small-cell lung carcinomaD002289——952——15
MyofibromaD047708———211—215
Male breast neoplasmsD018567——152—29
Anorexia nervosaD000856EFO_0004215F50.0263——9
Diabetes mellitusD003920EFO_0000400E08-E134—1—38
AnorexiaD000855—R63.0243——7
Show 54 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tissue adhesionsD000267——31——1114
Type 2 diabetes mellitusD003924EFO_0001360E11111——112
Premature birthD047928EFO_0003917O6033——610
Ovarian epithelial carcinomaD000077216——65———9
Covid-19D000086382—U07.1—4——48
Uterine cervical neoplasmsD002583——44——27
AdenocarcinomaD000230——25———6
InflammationD007249MP_0001845—13——26
Colorectal neoplasmsD015179——23——15
Squamous cell carcinoma of head and neckD000077195——45———5
Show 102 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Therapeutic equivalencyD013810——10———111
PharmacokineticsD010599——10————10
PregnancyD011247EFO_0002950Z33.12———68
Drug interactionsD004347——6———17
Hepatitis cD006526—B19.26————6
PainD010146EFO_0003843R521———34
TransgenesD019076——1———23
Kidney diseasesD007674EFO_0003086N081———23
PsoriasisD011565EFO_0000676L402———13
Type 1 diabetes mellitusD003922EFO_0001359E101———12
Show 47 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Venous thromboembolismD054556EFO_0004286I74————44
Menstrual cycleD008597——————33
Cerebrospinal fluid leakD065634—G96.0————33
In vitro oocyte maturation techniquesD059471——————22
Traumatic brain injuriesD000070642—S06————22
Autonomic nervous system diseasesD001342EFO_0009532G90————22
Vascular stiffnessD059289——————22
Psychological sexual dysfunctionsD020018—F52.0————22
Pathologic dilatationD004108——————22
Blood pressureD001794EFO_0004325—————22
Show 110 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEstradiol valerate
INNestradiol valerate
Description
Estradiol valerate is a steroid ester.
Classification
Small molecule
Drug classestrogens
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C
Identifiers
PDB—
CAS-ID979-32-8
RxCUI—
ChEMBL IDCHEMBL1511
ChEBI ID31561
PubChem CID13791
DrugBankDB13956
UNII IDOKG364O896 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Myfembree – Myovant Sciences
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Bijuva – TherapeuticsMD
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Divigel – RVL Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Ryeqo – Myovant Sciences
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Imvexxy – TherapeuticsMD
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Estradiol – Amneal Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,516 documents
View more details
Safety
Black-box Warning
Black-box warning for: Bijuva, Climara, Climara pro, Climarapro, Delestrogen, Divigel, Elestrin, Estrace, Estradiol valerate, Estradiol valerate and estradiol valerate/dienogest, Estring, Estrogel, Evamist, Femring, Imvexxy, Menostar, Minivelle, Natazia, Vagifem, Vivelle dot, Vivelle-dot
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
30,626 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use